018680.KS · 서울제약
South Korea · RS rating 14 · As of 2026-10-14
| Price | 1,900.00 KRW |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 46 / 13 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 4 / 47 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -68.8% |
| Sales growth Q/Q | -2.5% |
| Distance from 52-week high | +41.2% |
| Market cap (USD) | $16.8M |